Johnston S - Search Results

1

Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment.

Drury SC, Detre S, Leary A, Salter J, Reis-Filho J, Barbashina V, Marchio C, Lopez-Knowles E, Ghazoui Z, Habben K, Arbogast S, Johnston S, Dowsett M. Drury SC, et al. Among authors: johnston s. Endocr Relat Cancer. 2011 Aug 30;18(5):565-77. doi: 10.1530/ERC-10-0046. Print 2011 Oct. Endocr Relat Cancer. 2011. PMID: 21734071

2

Growth factor signalling and response to endocrine therapy: the Royal Marsden Experience.

Dowsett M, Johnston S, Martin LA, Salter J, Hills M, Detre S, Gutierrez MC, Mohsin SK, Shou J, Allred DC, Schiff R, Osborne CK, Smith I. Dowsett M, et al. Among authors: johnston s. Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S113-7. doi: 10.1677/erc.1.01044. Endocr Relat Cancer. 2005. PMID: 16113087 Review.

3

Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer.

Irshad S, Gillett C, Pinder SE, A'hern RP, Dowsett M, Ellis IO, Bartlett JM, Bliss JM, Hanby A, Johnston S, Barrett-Lee P, Ellis P, Tutt A. Irshad S, et al. Among authors: johnston s. Breast Cancer Res Treat. 2014 Apr;144(2):331-41. doi: 10.1007/s10549-014-2855-4. Epub 2014 Feb 12. Breast Cancer Res Treat. 2014. PMID: 24519386 Clinical Trial.

4

Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre.

Syed BM, Al-Khyatt W, Johnston SJ, Wong DW, Winterbottom L, Kennedy H, Green AR, Morgan DA, Ellis IO, Cheung KL. Syed BM, et al. Among authors: johnston sj. Br J Cancer. 2011 Apr 26;104(9):1393-400. doi: 10.1038/bjc.2011.105. Epub 2011 Mar 29. Br J Cancer. 2011. PMID: 21448163 Free PMC article.

5

Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair.

Johnston SJ, Ahmad D, Aleskandarany MA, Kurozumi S, Nolan CC, Diez-Rodriguez M, Green AR, Rakha EA. Johnston SJ, et al. BMC Cancer. 2018 Oct 23;18(1):1027. doi: 10.1186/s12885-018-4924-2. BMC Cancer. 2018. PMID: 30352570 Free PMC article.

6

A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unit.

Brunetto AT, Sarker D, Papadatos-Pastos D, Fehrmann R, Kaye SB, Johnston S, Allen M, De Bono JS, Swanton C. Brunetto AT, et al. Among authors: johnston s. Br J Cancer. 2010 Aug 24;103(5):607-12. doi: 10.1038/sj.bjc.6605812. Epub 2010 Jul 27. Br J Cancer. 2010. PMID: 20664586 Free PMC article.

7

Current issues with luminal subtype classification in terms of prediction of benefit from endocrine therapy in early breast cancer.

Alfarsi L, Johnston S, Liu DX, Rakha E, Green AR. Alfarsi L, et al. Among authors: johnston s. Histopathology. 2018 Oct;73(4):545-558. doi: 10.1111/his.13523. Epub 2018 May 28. Histopathology. 2018. PMID: 29603357 Review.

8

Is capecitabine efficacious in triple negative metastatic breast cancer?

Kotsori AA, Dolly S, Sheri A, Parton M, Shaunak N, Ashley S, Walsh G, Johnston S, Smith IE. Kotsori AA, et al. Among authors: johnston s. Oncology. 2010;79(5-6):331-6. doi: 10.1159/000323175. Epub 2011 Mar 23. Oncology. 2010. PMID: 21430400

9

Fulvestrant and the sequential endocrine cascade for advanced breast cancer.

Johnston S. Johnston S. Br J Cancer. 2004 Mar;90 Suppl 1(Suppl 1):S15-8. doi: 10.1038/sj.bjc.6601632. Br J Cancer. 2004. PMID: 15094760 Free PMC article. Review.

10

Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer.

Kurozumi S, Joseph C, Raafat S, Sonbul S, Kariri Y, Alsaeed S, Pigera M, Alsaleem M, Nolan CC, Johnston SJ, Aleskandarany MA, Ogden A, Fujii T, Shirabe K, Martin SG, Alshankyty I, Mongan NP, Ellis IO, Green AR, Rakha EA. Kurozumi S, et al. Among authors: johnston sj. Breast Cancer Res Treat. 2019 Jul;176(1):63-73. doi: 10.1007/s10549-019-05216-w. Epub 2019 Apr 2. Breast Cancer Res Treat. 2019. PMID: 30941650

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,330 results

Search Page